CA1132561A - Hydroxy pyrimidine derivatives - Google Patents

Hydroxy pyrimidine derivatives

Info

Publication number
CA1132561A
CA1132561A CA346,981A CA346981A CA1132561A CA 1132561 A CA1132561 A CA 1132561A CA 346981 A CA346981 A CA 346981A CA 1132561 A CA1132561 A CA 1132561A
Authority
CA
Canada
Prior art keywords
pyrimidine
isopropylamino
hydroxy
preparing
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA346,981A
Other languages
English (en)
French (fr)
Inventor
Andre Esanu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe dEtudes de Produits Chimiques SA
Original Assignee
Societe dEtudes de Produits Chimiques SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26270867&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA1132561(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Societe dEtudes de Produits Chimiques SA filed Critical Societe dEtudes de Produits Chimiques SA
Application granted granted Critical
Publication of CA1132561A publication Critical patent/CA1132561A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA346,981A 1979-03-10 1980-03-04 Hydroxy pyrimidine derivatives Expired CA1132561A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB7908494 1979-03-10
GB79.08494 1979-03-10
GB7914987 1979-04-30
GB79.14987 1979-04-30

Publications (1)

Publication Number Publication Date
CA1132561A true CA1132561A (en) 1982-09-28

Family

ID=26270867

Family Applications (1)

Application Number Title Priority Date Filing Date
CA346,981A Expired CA1132561A (en) 1979-03-10 1980-03-04 Hydroxy pyrimidine derivatives

Country Status (24)

Country Link
JP (1) JPS55122768A (it)
AR (1) AR222691A1 (it)
AU (1) AU533547B2 (it)
BE (1) BE881752A (it)
CA (1) CA1132561A (it)
CH (1) CH644368A5 (it)
DE (3) DE3009071C2 (it)
EG (1) EG14282A (it)
FI (1) FI66357C (it)
FR (2) FR2451191A1 (it)
GB (1) GB2045756B (it)
HK (1) HK55383A (it)
IE (1) IE49547B1 (it)
IN (1) IN153791B (it)
LU (1) LU82185A1 (it)
MX (1) MX6218E (it)
MY (1) MY8400200A (it)
NL (1) NL184833C (it)
NO (1) NO154054C (it)
NZ (1) NZ192927A (it)
OA (1) OA06484A (it)
PT (1) PT70882A (it)
SE (1) SE435180B (it)
SG (1) SG22683G (it)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE894517A (fr) * 1981-10-16 1983-01-17 Sod Conseils Rech Applic Nouveau derive de l'isopropylamino pyrimidine, sa preparation et composition therapeutiques a base de ses composes
US4673677A (en) * 1983-10-03 1987-06-16 Pfizer Inc. Method for treatment of gastrointestinal disorders
US4554276A (en) * 1983-10-03 1985-11-19 Pfizer Inc. 2-Amino-5-hydroxy-4-methylpyrimidine derivatives
US4711888A (en) 1985-07-24 1987-12-08 Pfizer Inc. Hydroxy and alkoxy pyrimidines
WO1989000423A1 (en) * 1987-07-09 1989-01-26 Pfizer Inc. 2-amino-5-hydroxy-4-pyrimidones
US4910204A (en) * 1988-06-28 1990-03-20 Pfizer Inc. 2-amino-5-hydroxy-4-pyrimidones
HU206337B (en) * 1988-12-29 1992-10-28 Mitsui Petrochemical Ind Process for producing pyrimidine derivatives and pharmaceutical compositions
US5264435A (en) * 1988-12-29 1993-11-23 Mitsui Petrochemical Industries, Ltd. Pyrimidines and their pharmaceutical acceptable salts, and their use as medicines
US4940712A (en) * 1989-05-26 1990-07-10 Pfizer Inc. Derivatives of hydroxyprimidines as leukotriene synthesis inhibitors
US5270319A (en) * 1991-09-09 1993-12-14 Warner-Lambert Company 5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents
US5220025A (en) * 1992-02-24 1993-06-15 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US5196431A (en) * 1992-02-24 1993-03-23 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-buthyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US9133212B1 (en) * 2005-06-15 2015-09-15 Vanderbilt University Inhibitors of hemeprotein-catalyzed lipid peroxidation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB741667A (en) * 1952-12-05 1955-12-07 Ici Ltd New pyrimidine derivatives
GB756189A (en) * 1954-02-01 1956-08-29 Ici Ltd New pyrimidine derivatives
ZA711152B (en) * 1970-03-02 1971-11-24 Ici Ltd Manufacture of pyrimidines
GB1525995A (en) * 1976-02-18 1978-09-27 Soc D Etudes Prod Chimique Aminopyrimidine salt

Also Published As

Publication number Publication date
IE49547B1 (en) 1985-10-30
FI66357C (fi) 1984-10-10
HK55383A (en) 1983-11-25
FI800566A (fi) 1980-09-11
GB2045756B (en) 1983-01-26
DE3009071A1 (de) 1980-09-11
EG14282A (en) 1983-09-30
NZ192927A (en) 1981-07-13
JPS55122768A (en) 1980-09-20
SE435180B (sv) 1984-09-10
DE3050999C2 (de) 1986-08-14
PT70882A (en) 1980-03-01
LU82185A1 (fr) 1980-06-06
DE3016752A1 (de) 1980-12-04
NL184468B (nl) 1989-03-01
IN153791B (it) 1984-08-18
FR2451191A1 (fr) 1980-10-10
NO154054C (no) 1986-07-09
OA06484A (fr) 1981-07-31
SE8001812L (sv) 1980-09-11
NL184833C (nl) 1989-11-16
DE3050999A1 (it) 1985-08-14
FR2451191B1 (it) 1983-04-29
DE3009071C2 (de) 1985-11-14
SG22683G (en) 1983-12-16
NO800664L (no) 1980-09-11
FI66357B (fi) 1984-06-29
GB2045756A (en) 1980-11-05
FR2451370B1 (it) 1983-05-13
CH644368A5 (en) 1984-07-31
MX6218E (es) 1984-12-21
FR2451370A1 (fr) 1980-10-10
NL184833B (nl) 1989-06-16
AU533547B2 (en) 1983-12-01
JPS6126996B2 (it) 1986-06-23
AR222691A1 (es) 1981-06-15
AU5624880A (en) 1980-09-18
DE3016752C2 (it) 1987-06-25
IE800477L (en) 1980-09-10
NO154054B (no) 1986-04-01
NL8001289A (nl) 1980-09-12
MY8400200A (en) 1984-12-31
BE881752A (fr) 1980-05-30

Similar Documents

Publication Publication Date Title
CA1132561A (en) Hydroxy pyrimidine derivatives
EP0005528B1 (en) Imidazole derivatives, their preparation and pharmaceutical compositions
EP0266349B1 (de) Tricyclische indolderivate, herstellung und anwendung als arzneimittel
DE2366106B1 (de) 2-Amino-6,7-dimethoxy-4-(methoxysubstituierte-1,2,3,4-tetrahydroisochinolin-2-yl)-chinazolinderivate,Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
RU2254330C2 (ru) Кислотно-аддитивные нитратные соли соединений и фармацевтическая композиция
KR840001132B1 (ko) 치환된 β-옥소-α-페닐-카바모일-피롤프로피오니트릴의 제조방법
JPH0526782B2 (it)
US5451606A (en) Anthraquinone compounds useful to treat osteoarticular conditions, pharmaceutical compositions and method of treatment
EP0096279B1 (de) N-(2-Methoxyethyl)-noroxymorphon, dessen Säureadditionssalze, diese enthaltende Arzneimittel und Verfahren zu deren Herstellung
MXPA02000033A (es) Polimorfos de un diclorhidrato cristalino de azobiciclo (2, 2, 2)oct-3-ilamina y sus composiciones farmaceuticas.
JPS63295561A (ja) ２−キノロン誘導体
IE49239B1 (en) Novel 2-(3,4-disubstituted-phenylimino)-imidazolidines
WO1995025732A1 (en) N-p-HALOBENZOYLMETHYL DERIVATIVES OF 4-(p-FLUOROPHENYL)-3-((3,4-METHYLENE-DIOXY)PHENOXY)METHYL)PIPERIDINE
DE2909646C3 (de) N-Alkenylmoranolinderivate
DE2218221C3 (de) Verfahren zur Herstellung von 2,4-Diamino-5-(3,43-trimethoxybenzyO-pyrimidin
US3966779A (en) Thymol derivatives and a process for their preparation
CA1132562A (en) Halogeno derivatives of isopropylamino pyrimidine, their preparation and therapeutic use
DE2139083A1 (de) Substituierte pyrimidine, verfahren zu deren herstellung und sie enthaltende arzneimittel
GB2054556A (en) Preparation of hydroxy derivatives of 2-isopropylamino-pyrimidine
DE2650366C3 (de) Verwendung eines 5-Fluoruracilde-
EP1813602A1 (en) Crystal of two-ring heterocyclic sulfonamide compound
US4185114A (en) Sulfur-containing N-benzylamino-acids and salts thereof
KR840001985B1 (ko) 이소프로필 아미노-피리미딘 하이드록시 유도체의 제법
US4187311A (en) 3-Aryloxy-1-carboalkoxyethylpyridinium compounds and compositions
JP2860385B2 (ja) ビスべンジルイソキノリン誘導体

Legal Events

Date Code Title Description
MKEX Expiry